3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Urinary Tract Infections
1
Thrombocytopenia
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Herpes Simplex
1
Hemophilia A
1
Hematologic Neoplasms
1
Hemangioma, Capillary
1
Interventions
eltrombopag
9
avatrombopag
6
Platelet Transfusion
6
romiplostim
4
Tranexamic Acid
3
Radiotherapy
3
Cytarabine
3
oprelvekin
2
hetrombopag
2
Tretinoin
2
Peripheral Blood Stem Cell Transplantation
2
Filgrastim
2
Cyclophosphamide
2
Carboplatin
2
Busulfan
2
Amplified Fragment Length Polymorphism Analysis
2
sodium thiosulfate
1
siltuximab
1
raltitrexed
1
pegfilgrastim
1
ofatumumab
1
niraparib
1
leridistim
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
apixaban
1
Vorinostat
1
Vitamin B 12
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thrombocytopenia
×
Aminocaproic Acid
×
Clear all
NCT02074436
2022-07-19
PROBLEMA
Emory University
Phase 2
Terminated
29 enrolled
10 charts